With obesity off the charts, big pharma is racing to bring new drugs to market. Many of the newbie medications tackle the metabolic downsides of obesity: glucose intolerance, high cholesterol and fatty liver. While drugs may be somewhat effective, they can be costly (especially in the United States) … [Read more...] about As Fatty Liver Spreads, Probiotics Enter the Fray